Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Thomas F. Wood"'
Autor:
Ping Xu, Brian Bickford, Mohammad Salman Hamdani, Thomas F. Wood, William H. Hersh, Cheslan K. Simpson, Arnold L. Rheingold, Jonathan E. Grob
Publikováno v:
The Journal of Organic Chemistry. 69:2153-2163
Reaction of the N-toluenesulfonyl derivatives of (S)-alanine, phenylalanine, and valine (4−6) with PhPCl2 gave in high yield the 4-methyl, benzyl, and isopropyl derivatives (7−9) of 2-phenyl-1-p-toluenesulfonyl-1,3,2-oxazaphospholidin-5-one. The
Autor:
Dean T. Nora, David P. Allegra, Thomas F. Wood, Leland J. Foshag, Richard J. Bleicher, Anton J. Bilchik
Publikováno v:
Annals of Surgical Oncology. 10:52-58
Radiofrequency ablation (RFA) is a promising technique for unresectable hepatic malignancies. We reviewed our RFA experience to identify variables affecting local recurrence.Patients undergoing RFA between 1997 and 2001 were reviewed for demographics
Autor:
Sakunthala Muthugounder, Anton J. Bilchik, Carlos A. Perez, Mepur H. Ravindranath, Thomas F. Wood, Donald L. Morton, Daniel Soh, Alexandra Gonzales
Publikováno v:
Cryobiology. 45:10-21
Cryosurgical ablation (CSA) of tumors induces disruptive necrosis. Necrosis may release tumor gangliosides into circulation and they may augment serum antiganglioside antibodies depending on the nature of gangliosides released. The hypothesis is test
Publikováno v:
The American Surgeon. 68:561-565
Encouraging results from our previous studies of sentinel lymph node (SLN) mapping in colorectal cancer (CRC) prompted investigation of its feasibility and accuracy during laparoscopic colectomy for early CRC. Between 1996 and 2000,14 patients with c
Autor:
Anton J. Bilchik, Donald L. Morton, Dean T. Nora, R.A.E.M. Tollenaar, Roderick R. Turner, C.J.H. van de Velde, Dave S.B. Hoon, Thomas F. Wood
Publikováno v:
European Journal of Cancer. 38:977-985
Approximately one-third of node-negative colon cancers will recur, possibly due to understaging and inadequate pathological examination of lymph nodes (LNs). We evaluated the sensitivity, accuracy and feasibility of staging based on lymphatic mapping
Autor:
Anton J. Bilchik, Dave S.B. Hoon, He-Jing Wang, Donald L. Morton, Roderick R. Turner, Stuart Sostrin, Sukamal Saha, James A. Stonecypher, Thomas F. Wood, David Wiese
Publikováno v:
Journal of Clinical Oncology. 19:1128-1136
PURPOSE: Approximately 30% of patients with American Joint Committee on Cancer stage I or II colorectal cancer (CRC) develop systemic disease. We hypothesized that multimarker reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of senti
Publikováno v:
The Oncologist. 6:24-33
Radiofrequency ablation (RFA) is increasingly used for the local destruction of unresectable hepatic malignancies. Relative contraindications include tumors in proximity to vital structures that may be injured by RFA and lesions whose size exceeds th
Autor:
Anton J. Bilchik, Thomas F. Wood
Publikováno v:
Oncology Issues. 16:17-20
Autor:
Thomas F. Wood, George J. Tsioulias, Donald L. Morton, Decio Rangel, William Hutchinson, Leland J. Foshag, Roderick R. Turner, Anton J. Bilchik
Publikováno v:
The American Surgeon. 66:998-1003
Approximately 30 per cent of patients with early colorectal carcinoma (CRC) develop systemic disease. A subgroup of these patients may harbor occult micrometastatic disease and might benefit from adjuvant chemotherapy. We investigated sentinel lymph
Autor:
Mathew H. Chung, Leland J. Foshag, Anton J. Bilchik, David P. Allegra, Thomas F. Wood, D. M. Rose
Publikováno v:
Annals of Surgical Oncology. 7:593-600
Radiofrequency ablation (RFA) is increasingly used for the local destruction of unresectable hepatic malignancies. There is little information on its optimal approach or potential complications.Since late 1997, we have undertaken 91 RFA procedures to